BioSig Technologies, Inc., a medical technology company, provides digital signal processing technology platform services in the United States. The company offers PURE EP Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. It has a research agreement with Mayo Foundation with the right to sublicense for patent applications in the fields of signal processing, physiologic recording, electrophysiology recording, electrophysiology software, and autonomics to develop, make, and offer for sale. The company also designs and develops an online platform for real-world asset (RWA) tokenization. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Los Angeles, California. Show more

Location: 12424 Wilshire Blvd, Los Angeles, CA, 90025, United States | Website: https://www.biosig.com | Industry: Medical Devices | Sector: Healthcare

Market Cap

215.2M

52 Wk Range

$0.23 - $14.11

Previous Close

$4.45

Open

$4.36

Volume

3,012,946

Day Range

$4.36 - $6.12

Enterprise Value

215.6M

Cash

2.82M

Avg Qtr Burn

-1.089M

Insider Ownership

28.73%

Institutional Own.

28.66%

Qtr Updated

06/30/25

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
PURE EP™ (device) Details Heart disease, Medical device	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Merimepodib (MMPD) Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.